WO2021001713A1
|
|
Process for the preparation of (s)-netarsudil, its salts & polymorphs
|
WO2018042393A1
|
|
Novel process for the preparation of brivaracetam
|
WO2016166733A1
|
|
A process for preparing a pharmaceutical composition comprising rivaroxaban
|
WO2016120746A1
|
|
A pharmaceutical composition comprising roflumilast
|
WO2015173779A1
|
|
Process for the preparation of teneligliptin and its novel intermediates
|
US2015119371A1
|
|
Topical pharmaceutical compositions of antibiotics and steroidal anti inflammatory agents
|
EP2749556A1
|
|
An improved process for the preparation of pure cyamemazine and salts thereof
|
WO2014002011A1
|
|
Micronized particles of olmesartan medoxomil and pharmaceutical composition thereof
|
WO2013179253A1
|
|
Fixed dose combination comprising nsaid and steroidal anti-inflammatory agent for treating post operative ocular inflammation
|
WO2013168032A1
|
|
Pharmaceutical compositions comprising rasagiline
|
WO2013065029A1
|
|
Fixed dose combination containing moxifloxacin and prednisolone for treatment of ocular infections
|
WO2013068876A1
|
|
Methods and compositions for treating ocular allergy
|
WO2013061269A1
|
|
Combinations of loteprednol and olopatadine for the treatment of ocular allergies
|
WO2013057569A2
|
|
Extended release pharmaceutical composition containing amoxicillin and clavulanic acid
|
WO2013054178A2
|
|
Extended release pharmaceutical compositions containing carbamazepine
|
WO2014009767A1
|
|
An improved process for the preparation of 1-aryl 2-aminomethyl cyclopropane carboxyamide (z) derivatives, their isomers and salts
|
US2013034605A1
|
|
Extended release pharmaceutical compositions containing paliperidone
|
WO2012014052A2
|
|
Novel coated extended release pharmaceutical compositions containing paliperidone
|
WO2011161504A1
|
|
Extended release formulations containing darifenacin or pharmaceutically acceptable salts thereof
|
US2011159092A1
|
|
Extended release pharmaceutical composition comprising linezolid and process for preparing the same
|